Tyrosinase Inhibition Mechanisms in Skin Applications

Tyrosinase is a copper‐containing oxidase catalysing the rate‐limiting steps of melanin biosynthesis. Overactivity of this enzyme contributes to hyperpigmentation disorders and uneven skin tone, stimulating the development of inhibitors for both cosmetic and therapeutic use. In skin applications, inhibitory mechanisms include direct chelation of the dinuclear copper centre, competitive displacement of native phenolic substrates, allosteric modulation of active‐site geometry and scavenging of reactive quinone intermediates. Crystallographic and spectroscopic analyses have revealed significant flexibility within the copper‐binding site, offering new avenues for structure‐guided inhibitor design that can discriminate between human and non‐human tyrosinases. Advances in formulation science—such as encapsulation in lipid nanoparticles and incorporation into hydrogel matrices—have further enhanced dermal penetration, controlled release and biocompatibility. Globally, these developments underpin treatments for melasma, post‐inflammatory hyperpigmentation and age‐related pigmentation changes, reflecting the broad significance of tyrosinase inhibition in dermatology and cosmetology.

Research from Nature Portfolio

Recent structural and kinetic investigations have clarified the inhibition mechanisms of two extensively used depigmenting agents. High-resolution crystal structures of tyrosinase in complex with kojic acid demonstrated that this compound binds at the periphery of the active site, acting as a mixed inhibitor that both chelates copper ions and disrupts substrate orientation. Parallel studies of hydroquinone revealed its dual role as a reversible substrate and inhibitor, dependent on the oxidation state and coordination environment of the dinuclear copper centre. Binding‐constant measurements and molecular modelling corroborated these findings, resolving ambiguities in their modes of action and providing a robust framework for the rational design of next‐generation inhibitors with enhanced specificity and safety profiles.

Tyrosinase Inhibition Mechanisms in Skin Applications publication trend

The graph below shows the total number of articles in tyrosinase inhibition mechanisms in skin applications across all publications each year (not limited to Nature Index journals).

Technical terms

Tyrosinase: A copper-containing oxidase that catalyses the ortho-hydroxylation of monophenols and the oxidation of o-diphenols to o-quinones in melanin synthesis.

Melanogenesis: The biosynthetic pathway within melanocytes that produces melanin, involving tyrosinase and related enzymes.

Copper chelation: The binding of copper ions by an inhibitor molecule, preventing their participation in enzymatic catalysis.

Mixed inhibition: A mode of enzyme inhibition in which the inhibitor can bind to both the free enzyme and the enzyme–substrate complex, altering substrate affinity and catalytic rate.

Competitive inhibitor: A molecule that reversibly occupies the enzyme’s active site, directly competing with the natural substrate for binding.

References

1. A comprehensive review on tyrosinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry (2019).
2. Crystallographic Evidence That the Dinuclear Copper Center of Tyrosinase Is Flexible during Catalysis*. Journal of Biological Chemistry (2006).
3. p-Coumaric Acid as An Active Ingredient in Cosmetics: A Review Focusing on its Antimelanogenic Effects. Antioxidants (2019).
4. Natural and Bioinspired Phenolic Compounds as Tyrosinase Inhibitors for the Treatment of Skin Hyperpigmentation: Recent Advances. Cosmetics (2019).